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Abstract: MoStBioDat is a uniform data storage and extraction system with an extensive 
array of tools for structural similarity measures and pattern matching which is essential to 
facilitate the drug discovery process. Structure-based database screening has recently 
become a common and efficient technique in early stages of the drug development, shifting 
the emphasis from rational drug design into the probability domain of more or less random 
discovery. The virtual ligand screening (VLS), an approach based on high-throughput 
flexible docking, samples a virtually infinite molecular diversity of chemical libraries 
increasing the concentration of molecules with high binding affinity. The rapid process of 
subsequent examination of a large number of molecules in order to optimize the molecular 
diversity is an attractive alternative to the traditional methods of lead discovery. This paper 
presents the application of the MoStBioDat package not only as a data management 
platform but mainly in substructure searching. In particular, examples of the applications 
of MoStBioDat are discussed and analyzed. 
Keywords: combinatorial chemistry; virtual screening; relational database; ligand; 
macromolecule; MoStBioDat 
 
1. Introduction 
The formation of the receptor-ligand system is a complex phenomenon whose exploration is a 
challenging aim of contemporary chemistry and pharmacology. The awareness of the receptor 
structure targeted by a complementary bioeffector is a crucial point for identifying the lead structures 
OPEN ACCESS
Molecules 2009, 14                            
 
 
3437
both by in vitro (combinatorial chemistry) and in silico (HTS) screening. In fact, the receptor structure 
data are becoming more and more often available, which makes structure based methods, e.g. receptor 
based RD-QSAR, increasingly popular [1]. Similarly, we can observe an enormous interest in probing 
drug-receptor interactions using a large number of ligands in conjunction with molecular docking. 
Virtual screening with fragment based docking is a recent example [2-4]. 
Such computer-assisted simulations are the most progressive topic in present day drug design. This 
demands however the processing of enormous amounts of data. In turn it is the proper aggregation and 
organization of a chemical information dataset that enables massive virtual screening (VS). This is 
however hampered by the lack of the unified data standards. Among the steepest barriers to overcome 
in high-throughput screening studies is the limited number of suitable repositories of stored drug and 
drug target data. By offering a uniform data storage and retrieval mechanism different data might be 
compared and exchanged easily. ZINC is an example of a “drug-like” SDF ensemble of ligand 
structures that can be directly used as a basic source of data for Ligand [5]. The current version of the 
Ligand database contains approximately seven million compounds [6]. Chem DB is another database 
that includes approximately 4.1 million commercially available compounds [7,8]. 
Generally, several database systems with macromolecular data are also available publicly, but only 
a few combine the receptor-ligand data together. Moreover, practically in all cases the access to these 
data is limited to the respective web sites. The main goal of the current investigations was to provide 
an integrated software system, namely, the MoStBioDat [9,10] platform, for storing data in a unified 
format with an ensemble of tools for data manipulation. The major advantage of this platform relies on 
the possibility of being installed locally with a pretty simple database driven by the Python [11] 
package installation procedure. Users can establish their own hardware/software environment and data 
to import with a set of tools for storage, access and exchange of biological data. The modular 
architecture of the Python package also enables the extension of the system with necessary 
functionalities in the future. The whole MoStBioDat software can be freely downloaded from our web 
site. In the present publication we are reporting the current state of the project development. Moreover, 
we discuss here the product efficiency when applied to the analysis of the molecular diversity and 
molecular similarity of small molecules.  
2. Methods  
2.1. MoStBioDat architecture 
A detailed description of the MoStBioDat system can be found elsewhere [9]. A brief overview is 
given in Figure 1. Conceptually, the system architecture encompasses Storage and User Layers, 
respectively. This system resembles the architecture of the BioSimGrid project, which has a similar 
structural layout [12,13]. Following the contemporary trends in the database technology the pragmatic 
relational approach has been applied to programming the Storage Layer that is in charge of storing and 
preserving data. Therefore, the database system has been designed to organize data relationally with 
parent-child key relationships that enable an efficient management of the stored datasets with the 
open-source MySQL as a database server [14]. The relational database system is composed of two 
major ingredients: Ligand and Macromolecule, respectively. The Ligand part consists of an ensemble 
of primary tables storing multiple molecule representations including line notation with the absolute 
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SMILES code, protonation state and conformational sampling, respectively. The topology of the 
Macromolecule database reflects the conventional PDB flat-file structure and data hierarchy. It 
contains a set of tables to store and retrieve original PDB data. The entire system, including Ligand 
and Macromolecule, is integrated together combining the knowledge of small molecules and their 
corresponding drug targets (Figure 2). The underlying complexity of parsing, validating, storing and 
extracting data is hidden in the middleware called Data Management Component, which provides an 
abstract layer with sets of services responsible for making data transparently available. The  
post-processing component in the User Layer called User Interface Component offers two modes of 
browsing the databases. The users have access to datasets with fully programmable Python command 
line helpful for more specific analysis, whereas novice users can apply the graphical user interface 
(GUI) – not implemented yet in the current prototype. A set of pretty mature Python libraries and 
programs, for instance MMTK, VMD or R, are freely available with all necessary simulation and 
visualization tools [15-17]. Practically, the entire system is based on the client-server architecture, 
although the current prototype was implemented and tested where both applications and a database 
server was running at a single PC location with Intel Pentium 4 CPU 3.4 GHz, 2GB RAM memory and 
1.5TB hard disk space available with GNU/Linux Debian 4.0 as a operating system. It should be 
emphasized that in the relationally designed systems the time/resource performance strongly depends 
on the manner of the query creation and the size of the database. 
Figure 1. The architecture of the MoStBioDat package. 
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Figure 2. The basic virtual ligand screening pipeline. 
 
2.2. ZINC database 
The ZINC database [5,6] was chosen as a basic set of structural data in order to avoid common 
problems with representation of compounds in the correct protonation, tautomeric and 3D 
conformational states. Moreover, ZINC offers the subsets of data especially prepared for docking. 
Thus, the data seem to be suitable to be integrated with macromolecular structures.  
2.3. Rapid screening of the ZINC database subset  
The rapid examination of a large number of molecular data stored in a database combined with the 
calculation of the metric quantifying the similarity with a given pattern is one of the fundamental tasks 
in chemoinformatics. This is performed by the analysis of the entire structure or substructure, which 
form a search query for identifying the ensemble of compounds fulfilling the global similarity criteria. 
In practice, similarity or diversity measures derived by comparing the presence and/or absence of 
features or the occurrences of substructures present in a molecule, are based on a abstract 
representations of certain structural features of a compound in form of the fixed-size binary fingerprint 
vector [18]. Characterizing a chemical structure in the binary form integrated with the efficient bit-
wise algorithms yield high-speed structural screening procedure, which in comparison with the 
precise, computationally demanding exact search results might produce a bit higher rate of false 
positives [19].  
Among different similarity measures and pattern matching procedures developed for molecular 
fingerprints applied as filtering methods identifying or eliminating drug-likeness of molecules, the 
Tanimoto coefficient [20,21] is the most common one. It defines the proportion of substructures in 
common between two molecules which is expressed by the following formula:  
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where:  
 xyn  - the number of bits set into 1 shared in the fingerprint of molecule x and y 
 xn  - the number of bits set into 1 in the molecule x 
 yn  - the number of bits set into 1 in the molecule y 
Conceptually, the procedure of finding a particular pattern in a molecule might be interpreted as 
string regular expressions describing the search criteria. All compounds which share a common 
substructure might be identified using the straightforward extension of SMILES notation – the 
SMARTS pattern [20]. 
It is assumed that the largest common component that appears in structurally related drugs might 
determinate their biological activity. The Maximum Common Substructure (MCS) approach is an 
alternative method of pattern matching which provides a similarity score for a pair of structures used 
as a metric for ranking the molecular similarity [22,23]. The conversion of the MCS-based procedure 
into the CPU intensive maximum clique detection problem makes it impossible to be applicable in the 
high-speed database screening. 
The analysis of some molecular properties allowed identification of those that are important for a 
drug’s pharmacokinetics (ADMET). The quantitative filter used for the drug-like molecule searches 
has also been formed by Lipinski’s Rule of Five (RO5) [24].The property space was restricted to the 
range of values defined by the octanol/water partition coefficient (ClogP ≤ 5), the molecular weight 
(MW ≤ 500), the number of hydrogen bond donors (HBD ≤ 5) and hydrogen bond acceptors  
(HBA ≤ 10), respectively. Roughly speaking, the violation of the above conditions might discriminate 
between prospective drugs and non-drugs, but RO5 does not represent precise rules sufficient for 
defining druglikeness [25]. Moreover, the distribution of the molecular weights for drugs and non 
drugs has also been neglected recently [26]. Taking into account more restrictive conditions  
(MW ≤ 460, -4 ≤ ClogP ≤ 4.2, HBD ≤ 5, HBA ≤ 9) the leadlikeness criteria has been established to 
identify drug prototypes, which are optimized before obtaining the drug candidate status [27]. The 
leadlike-based strategy is also expected to be applicable for database sampling as a integral part of the 
continual enrichment of the HTS procedure.  
2. Results and Discussion 
The calculations of several pretty helpful statistics on small molecules (Ligand database), primarily 
intended as coding examples, have been conducted on the trial “drug-like” subset of 24,000 molecules 
taken from the ZINC database. The histogram counting the number of molecules in the function of 
commonly derived molecular descriptors such H-bond donors (hbd), H-bond acceptors (hba) or 
number of rotatable bonds (nrb) is shown in Figure 3. Additionally, the pairwise comparison 
displaying the mutual relationship between the calculated logP versus molecular weight and apolar 
desolvation versus polar desolvation are specified in Figures 4a and 4b, respectively. 
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Figure 3. Histogram of some molecular descriptors calculated during screening of the 
Ligand database (hbd – H-bond donors, hba – H-bond acceptors, nrb – number of rotatable 
bonds).  
 
The distribution of the structural similarity within the ensemble of small molecules to an arbitrary 
chosen molecule of 2-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(2,3,4-trihydroxyphenyl)ethanone indi-
cated by its Tanimoto coefficient with respect to Daylight-type fingerprint is introduced in Figure 5. 
The substructure bias, assessing the level of molecular similarity, is accomplished by setting the 
similarity measure ranging from 0.1 to 1.0. 
Figure 4. The distribution of the calculated logP vs. molecular weight (a) and apolar 
desolvation vs. polar desolvation (b). 
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Figure 5. The histogram representing the similarity score distribution for the entire subset 
of molecules in the Ligand database calculated for the chosen search structure. The 
substructure bias, assessing the level of molecular similarity, is accomplished by setting 
the similarity measure ranging from 0.1 to 1.0. The examples of molecules with Tanimoto 
coefficient ≥ 0.7 are given in the internal frame. 
 
3. Experimental Section 
3.1. Distribution 
A brief description of the current development status along with the latest released version of the 
package to download and the generated documentation are available from the following web address: 
http://www.chemoinformatyka.us.edu.pl/mostbiodat/. Under this address the whole program can be 
downloaded for local installation on a user’s machine under the terms of a GPL version 3 license. The 
system can be installed on under the Linux system. To obtain full module functionality the academic 
OpenEye license is needed. The rest of the applied Python libraries are distributed under the GPL 
license. 
3.2. Installation and operation of the MoStBioDat package 
The system can be at the moment be downloaded from our website to be locally installed, operated 
and evaluated. This can be operated in a command line mode which is a limitation (mainly for 
beginners). It is very common to operate a variety of programs in such a manner. Being aware of the 
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limitations of the command line access, especially for the beginners, future developments of the 
system will be equipped with a graphical user interface accessible via web browser. It should be 
emphasized that we have implemented the first prototype for evaluation and correction. Despite the 
lack of the GUI, it is still possible to establish a user-friendly text-mode environment using f.e. Eclipse 
with PyDev module. The MoStBioDat package with the ensemble of libraries may be regarded as a 
Python toolkit for data manipulation, what facilitates the program creation using some predefined 
blocks. This manner of programming is used in other packages f.e. mmLib, Pybel, rdKit, OEChem. 
The MoStBioDat package is still being developed and refined taking into consideration user remarks. 
The listing below gives an example of the substructure search (cf. paragraph 2.3) using the 
Tanimoto coefficient and Lipinski’s Rule of Five: 
A=DB2SmiDict(host=’localhost’,db=’ligand’,user=’’,passwd=’’,path=’/tmp/Log’,filename=’db2smi’) 
B=SubStructSearch(smidict=A.readb(logdebug=False),path=’/tmp/Log’,filename=’smisubsearch’) 
 
### Tanimoto Search ### 
B.TanimotoSearch(refsmile=’Cc1cccccc1’,coeff=0.7, outfile=’/tmp/TanimotoSearch.txt’) 
 
### Lipinski’s Rule of File Search ### 
B.RO5Search(outfile=’/tmp/RO5Search.txt’,MolWT=500,HBA=10,HBD=5,LogP=5) 
3.3. Data format 
There is no restriction imposed on the source of data – the only limitation is the format of the input 
files (sdf or pdb). One can decided to use other remote sites, e.g., PubChem or DrugBank as a 
supplementary source of data, generally providing physical, chemical or biological properties of 
compounds. The data providing the topographical description of the particular compound are generally 
distributed in the mol or sdf file format. Additional set of properties is frequently offered in a separate 
spreadsheet with the canonical SMILES code to identify the compound. We have implemented two 
modules for the spreadsheet parsing so far (MoStBioDat/DataBase/ImportData/Data2DB/PropZINC, 
MoStBioDat/DataBase/ImportData/Data2DB/PropDrugBank). 
3.4. Substructure searches 
The OpenBabel’s [28] and OpenEye’s [29] functions have been applied to generate and compare 
the molecular fingerprints and the SMARTS matching in the SubstructureSearch module 
(TanimotoSearch, SMARTSearch, QuerySearch, MCSearch, CliqueSearch, RO5Search). 
4. Conclusions 
The main goal of this project was to provide an integrated software system for storing data in a 
unified format with an ensemble of tools for data manipulation. Conceptually, we have followed some 
known solutions trying to gather them together. However, the MoStBioDat one is designed to include 
both the ligand and macromolecule data. Generally, several database systems are publicly available 
with macromolecular or ligand data, but only a very few combine them together. Moreover, for almost 
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all of them, access to this data is limited to the corresponding web sites. The major advantage of the 
MoStBioDat platform relies on the possibility of being installed locally, which allows users to 
establish their own hardware/software environments and data to import with a set of tools for storage, 
access and exchange of the biological data.  
In the example of application we have shown the effective data manipulation within the “drug-like” 
subset of 24,000 molecules taken from ZINC database. This allowed for the rapid screening of the H-
bond donors, H-bond acceptors, number of rotatable bonds. The logP vs. molecular weight and apolar 
desolvation vs. polar desolvation relationships can also be plotted and analyzed easily. Finally, the 
MoStBioDat platform makes available rapid screening in a search for related molecules on the basis of 
similarity scores.  
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